Drug Addiction Treatment Market Size, Trends, and Insights By Treatment Centers (Residential Centers, Rehabilitation centers, Inpatient Centers, Others), By Drug Type (Tobacco/Nicotine and Vaping, Marijuana, Alcohol, Prescription and Over-the-Counter Medications, Synthetic Cannabinoids, Others), By Distribution Channel (Medical Stores, Hospital Pharmacies, Others), and By Region - Global Industry Overview, Statistical Data, Competitive Analysis, Share, Outlook, and Forecast 2024–2033
Report Snapshot
| Study Period: | 2024-2033 |
| Fastest Growing Market: | North America |
| Largest Market: | Asia-Pacific |
Major Players
- Alkermes Plc.
- Glenmark Pharmaceuticals
- Teva Pharmaceutical Industries Ltd
- Others
Reports Description
According to Custom Market Insights (CMI), the Global Drug Addiction Treatment Market size was estimated at USD 16.5 Billion in 2021 and is expected to reach USD 18.5 billion in 2022 and is expected to hit around USD 35 Billion by 2030, poised to grow at a compound annual growth rate (CAGR) of 15% from 2022 to 2030. Our research report offers a 360-degree view of the Drug Addiction Treatment market’s drivers and restraints, coupled with the impact they have on demand during the projection period. Also, the report examines global opportunities and competitive analysis for the Drug Addiction Treatment market.
- Addiction is a serious public health issue that continues to affect millions of people around the world, even as the revolutionary COVID-19 epidemic waged war on humanity. Alcohol, tobacco, and drug addiction are all on the rise, particularly in developing nations like China and India. Every year, approximately 6 million people die from tobacco addiction worldwide, and the numbers are rapidly rising. The annual increase in cigarette-related deaths has raised the pressure on governments and businesses worldwide to pass laws that will discourage tobacco use and addiction.
- In addition to tobacco addiction, alcohol and drug addiction are also on the rise, which is increasing the need for addiction therapy. The healthcare sector is currently adopting new technological advancements like telecommuting more frequently. Partnerships between application developers and healthcare practitioners are now growing significantly, and it is predicted that this trend will continue during the projected period.
- According to the National Institute on Drug Addiction, about 54% of drug addicts in the US are under the age of 18. The alarming statistics in other regions of the world that have compelled government authorities to raise awareness about addiction treatment are another reason that is projected to boost the rise of the global market for drug addiction therapy.
- Finding creative ways to improve addiction treatment on a worldwide level is one of the challenges currently plaguing the market for treating drug addiction. A number of experts believe that building addiction treatment centres that collaborate with rehabilitation and treatment centres is a promising strategy for achieving the objective. This approach is likely to significantly accelerate the conversion of cutting-edge scientific findings into workable addiction treatment procedures, which will likely drive the global market for drug addiction therapy.
Report Objective
The market size of these services offered by various market participants is taken into account in the study’s research of the global market for drug addiction treatment. The study also keeps an eye on key market drivers, underlying growth influencers, and significant vendors functioning in the sector in order to support the market forecasts and growth rates throughout the projected period of 2022–2030. The study also looks at how COVID-19 has generally impacted ecology. The study’s scope covers market size and forecasts for geographic, distribution, and drug type-specific treatment facilities.
| Feature of the Report | Details |
| Market Size in 2021 | USD 16.5 Billion |
| Projected Market Size in 2030 | USD 35 Billion |
| Market Size in 2022 | USD 18.5 Billion |
| CAGR Growth Rate | 15% CAGR (2022-2030) |
| Base Year | 2023 |
| Forecast Period | 2024-2033 |
| Prominent Players | Alkermes Plc., Glenmark Pharmaceuticals, Teva Pharmaceutical Industries Ltd., Titan Pharmaceuticals Inc., Pfizer Inc., Johnson & Johnson, GlaxoSmithKline plc., Perrigo Company plc., Cipla Limited, Dr. Reddy’s Laboratories Limited, Hikma Pharmaceuticals Plc., Indivior Inc., Mylan N.V., and Others |
| Key Segment | By Treatment Centers, Drug Type, Distribution Channel, and Region |
| Report Coverage | Revenue Estimation and Forecast, Company Profile, Competitive Landscape, Growth Factors and Recent Trends |
| Regional Scope | North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America |
| Buying Options | Request tailored purchasing options to fulfil your requirements for research. |
Key Market Dynamics
- The key variables influencing market revenue growth include the rise in drug dependence, drug-related mortality, and the usage of medication-assisted treatment (MAT). The industry is anticipated to see growth in revenue between 2022 and 2030 as a result of increasing government funding and efforts as well as raised public awareness of drug addiction.
- Drug overdose is one of the major factors in fatalities on a global scale. According to the Centers for Disease Control and Prevention, drug overdose deaths will claim the lives of nearly 91,000 Americans in 2020. The regular use of addictive substances and drug overdose, which are most commonly associated with attention-deficit hyperactivity disorder (ADHD) and intermittent explosive disorder, are said to have a significant impact on users’ mental health. An increase in the number of efforts and programmes created by governments and other organisations to raise awareness about drug addiction, the risks of drug use, and how to deal with drug-related difficulties is also contributing to the market revenue growth.
- For instance, in an effort to reduce drug use and the harm that drug users create, the Biden administration produced the National Drug Control Strategy in April 2022. Official solutions also provide a variety of unique perspectives on how to treat addicts, lessen the stigma attached to substance usage, and starve the underground market. Many countries have succeeded in modernising their drug laws, methods of enforcement, and therapies to addiction. For instance, Portugal, the first EU nation to legalise all drugs, has seen a decline in arrests and total illicit drug use.
The Tobacco/Nicotine Drug Addiction Treatment Segment Led the Drug Addiction Treatment Market
- Smoking increases the risk of lung cancer and cardiovascular disease. An estimated 8 million people every year pass away from tobacco-related diseases.
- Luckily, governments have recognised this issue and are acting forcefully to lower the number of fatalities brought on by drug usage. One of the reasons influencing the global market for drug addiction treatment is the fact that patients are opting for smoking cessation therapy as a result of being aware of the risks. The abuse of prescription drugs and government measures to stop it will also boost market growth.
- As cigarette smoking has become increasingly prevalent, options for treating tobacco and nicotine addiction have increased. The market will grow as drugs and nicotine replacement therapies that treat tobacco and nicotine addiction become more widely available.
Competitive Landscape
Drug addiction treatment is a fairly competitive industry, with both established and emerging major players. To maintain a strong position in the market, these competitors are employing a variety of strategies, including mergers, acquisitions, and alliances.
In-depth company profiles, product portfolios, insights into key brands and growth strategies, SWOT and strategy assessments of the companies, financial analysis, and analyst perspectives on the top players in this market are all covered in this report.
- 2022: Indivior PLC and Addex Therapeutics have worked together on the research and development of innovative oral gamma-aminobutyric acid subtype B positive allosteric modulator drug candidates. Addex Therapeutics is a clinical-stage pharmaceutical company. Indivior will provide the latter business with an extra US$900,000 for research financing pursuant to the terms of this Agreement.
- 2022: Pfizer, Inc. announced a new strategic partnership with Alex Therapeutics to deliver Cognitive Behavioral Therapy and Acceptance and Commitment Therapy to patients with nicotine addiction while individualised care is provided through digital therapeutics. This partnership is based on Alex Therapeutics’ AI-based platform. During the duration of its initial phase, this initiative will run in the German market.
Prominent Players:
- Alkermes Plc.
- Glenmark Pharmaceuticals
- Teva Pharmaceutical Industries Ltd.
- Titan Pharmaceuticals Inc.
- Pfizer Inc.
- Johnson & Johnson
- GlaxoSmithKline plc.
- Perrigo Company plc.
- Cipla Limited
- Reddy’s Laboratories Limited
- Hikma Pharmaceuticals Plc.
- Indivior Inc.
- Mylan N.V.
The global Drug Addiction Treatment market is segmented as follows:
By Treatment Centers
- Residential Centers
- Rehabilitation centers
- Inpatient Centers
- Others
By Drug Type
- Tobacco/Nicotine and Vaping
- Marijuana
- Alcohol
- Prescription and Over-the-Counter Medications
- Synthetic Cannabinoids
- Others
By Distribution Channel
- Medical Stores
- Hospital Pharmacies
- Others
By Region
North America
- U.S.
- Canada
- Mexico
- Rest of North America
Europe
- Germany
- France
- U.K.
- Italy
- Spain
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- New Zealand
- Australia
- South Korea
- Rest of Asia Pacific
The Middle East & Africa
- Saudi Arabia
- UAE
- Egypt
- Kuwait
- South Africa
- Rest of the Middle East & Africa
Latin America
- Brazil
- Argentina
- Rest of Latin America
Table of Contents
- Chapter 1. Preface
- 1.1 Report Description and Scope
- 1.2 Research scope
- 1.3 Research methodology
- 1.3.1 Market Research Type
- 1.3.2 Market research methodology
- Chapter 2. Executive Summary
- 2.1 Global Drug Addiction Treatment Market, (2022 – 2030) (USD Billion)
- 2.2 Global Drug Addiction Treatment Market : snapshot
- Chapter 3. Global Drug Addiction Treatment Market – Industry Analysis
- 3.1 Drug Addiction Treatment Market: Market Dynamics
- 3.2 Market Drivers
- 3.2.1 The increase in the prevalence of drug, alcohol and tobacco abuse
- 3.2.2 Rising public awareness of the harmful effects of substance misuse.
- 3.3 Market Restraints
- 3.4 Market Opportunities
- 3.5 Market Challenges
- 3.6 Porter’s Five Forces Analysis
- 3.7 Market Attractiveness Analysis
- 3.7.1 Market attractiveness analysis By Treatment Centers
- 3.7.2 Market attractiveness analysis By Drug Type
- 3.7.3 Market attractiveness analysis By Distribution Channel
- Chapter 4. Global Drug Addiction Treatment Market- Competitive Landscape
- 4.1 Company market share analysis
- 4.1.1 Global Drug Addiction Treatment Market: company market share, 2021
- 4.2 Strategic development
- 4.2.1 Acquisitions & mergers
- 4.2.2 New Product launches
- 4.2.3 Agreements, partnerships, cullaborations, and joint ventures
- 4.2.4 Research and development and Regional expansion
- 4.3 Price trend analysis
- 4.1 Company market share analysis
- Chapter 5. Global Drug Addiction Treatment Market – Treatment Centers Analysis
- 5.1 Global Drug Addiction Treatment Market overview: By Treatment Centers
- 5.1.1 Global Drug Addiction Treatment Market share, By Treatment Centers, 2021 and 2030
- 5.2 Residential Centers
- 5.2.1 Global Drug Addiction Treatment Market by Residential Centers, 2022 – 2030 (USD Billion)
- 5.3 Rehabilitation centers
- 5.3.1 Global Drug Addiction Treatment Market by Rehabilitation centers, 2022 – 2030 (USD Billion)
- 5.4 Inpatient Centers
- 5.4.1 Global Drug Addiction Treatment Market by Inpatient Centers, 2022 – 2030 (USD Billion)
- 5.5 Others
- 5.5.1 Global Drug Addiction Treatment Market by Others, 2022 – 2030 (USD Billion)
- 5.1 Global Drug Addiction Treatment Market overview: By Treatment Centers
- Chapter 6. Global Drug Addiction Treatment Market – Drug Type Analysis
- 6.1 Global Drug Addiction Treatment Market overview: By Drug Type
- 6.1.1 Global Drug Addiction Treatment Market share, By Drug Type, 2021 and 2030
- 6.2 Tobacco/Nicotine and Vaping
- 6.2.1 Global Drug Addiction Treatment Market by Tobacco/Nicotine and Vaping, 2022 – 2030 (USD Billion)
- 6.3 Marijuana
- 6.3.1 Global Drug Addiction Treatment Market by Marijuana, 2022 – 2030 (USD Billion)
- 6.4 Alcohol
- 6.4.1 Global Drug Addiction Treatment Market by Alcohol, 2022 – 2030 (USD Billion)
- 6.5 Prescription and Over-the-Counter Medications
- 6.5.1 Global Drug Addiction Treatment Market by Prescription and Over-the-Counter Medications, 2022 – 2030 (USD Billion)
- 6.6 Synthetic Cannabinoids
- 6.6.1 Global Drug Addiction Treatment Market by Synthetic Cannabinoids, 2022 – 2030 (USD Billion)
- 6.7 Others
- 6.7.1 Global Drug Addiction Treatment Market by Others, 2022 – 2030 (USD Billion)
- 6.1 Global Drug Addiction Treatment Market overview: By Drug Type
- Chapter 7. Global Drug Addiction Treatment Market – Distribution Channel Analysis
- 7.1 Global Drug Addiction Treatment Market overview: By Distribution Channel
- 7.1.1 Global Drug Addiction Treatment Market share, By Distribution Channel, 2021 and 2030
- 7.2 Medical Stores
- 7.2.1 Global Drug Addiction Treatment Market by Medical Stores, 2022 – 2030 (USD Billion)
- 7.3 Hospital Pharmacies
- 7.3.1 Global Drug Addiction Treatment Market by Hospital Pharmacies, 2022 – 2030 (USD Billion)
- 7.4 Others
- 7.4.1 Global Drug Addiction Treatment Market by Others, 2022 – 2030 (USD Billion)
- 7.1 Global Drug Addiction Treatment Market overview: By Distribution Channel
- Chapter 8. Drug Addiction Treatment Market – Regional Analysis
- 8.1 Global Drug Addiction Treatment Market Regional Overview
- 8.2 Global Drug Addiction Treatment Market Share, by Region, 2021 & 2030 (USD Billion)
- 8.3. North America
- 8.3.1 North America Drug Addiction Treatment Market, 2022 – 2030 (USD Billion)
- 8.3.1.1 North America Drug Addiction Treatment Market, by Country, 2022 – 2030 (USD Billion)
- 8.3.1 North America Drug Addiction Treatment Market, 2022 – 2030 (USD Billion)
- 8.4 North America Drug Addiction Treatment Market, by Treatment Centers, 2022 – 2030
- 8.4.1 North America Drug Addiction Treatment Market, by Treatment Centers, 2022 – 2030 (USD Billion)
- 8.5 North America Drug Addiction Treatment Market, by Drug Type, 2022 – 2030
- 8.5.1 North America Drug Addiction Treatment Market, by Drug Type, 2022 – 2030 (USD Billion)
- 8.6 North America Drug Addiction Treatment Market, by Distribution Channel, 2022 – 2030
- 8.6.1 North America Drug Addiction Treatment Market, by Distribution Channel, 2022 – 2030 (USD Billion)
- 8.7. Europe
- 8.7.1 Europe Drug Addiction Treatment Market, 2022 – 2030 (USD Billion)
- 8.7.1.1 Europe Drug Addiction Treatment Market, by Country, 2022 – 2030 (USD Billion)
- 8.7.1 Europe Drug Addiction Treatment Market, 2022 – 2030 (USD Billion)
- 8.8 Europe Drug Addiction Treatment Market, by Treatment Centers, 2022 – 2030
- 8.8.1 Europe Drug Addiction Treatment Market, by Treatment Centers, 2022 – 2030 (USD Billion)
- 8.9 Europe Drug Addiction Treatment Market, by Drug Type, 2022 – 2030
- 8.9.1 Europe Drug Addiction Treatment Market, by Drug Type, 2022 – 2030 (USD Billion)
- 8.10 Europe Drug Addiction Treatment Market, by Distribution Channel, 2022 – 2030
- 8.10.1 Europe Drug Addiction Treatment Market, by Distribution Channel, 2022 – 2030 (USD Billion)
- 8.11. Asia Pacific
- 8.11.1 Asia Pacific Drug Addiction Treatment Market, 2022 – 2030 (USD Billion)
- 8.11.1.1 Asia Pacific Drug Addiction Treatment Market, by Country, 2022 – 2030 (USD Billion)
- 8.11.1 Asia Pacific Drug Addiction Treatment Market, 2022 – 2030 (USD Billion)
- 8.12 Asia Pacific Drug Addiction Treatment Market, by Treatment Centers, 2022 – 2030
- 8.12.1 Asia Pacific Drug Addiction Treatment Market, by Treatment Centers, 2022 – 2030 (USD Billion)
- 8.13 Asia Pacific Drug Addiction Treatment Market, by Drug Type, 2022 – 2030
- 8.13.1 Asia Pacific Drug Addiction Treatment Market, by Drug Type, 2022 – 2030 (USD Billion)
- 8.14 Asia Pacific Drug Addiction Treatment Market, by Distribution Channel, 2022 – 2030
- 8.14.1 Asia Pacific Drug Addiction Treatment Market, by Distribution Channel, 2022 – 2030 (USD Billion)
- 8.15. Latin America
- 8.15.1 Latin America Drug Addiction Treatment Market, 2022 – 2030 (USD Billion)
- 8.15.1.1 Latin America Drug Addiction Treatment Market, by Country, 2022 – 2030 (USD Billion)
- 8.15.1 Latin America Drug Addiction Treatment Market, 2022 – 2030 (USD Billion)
- 8.16 Latin America Drug Addiction Treatment Market, by Treatment Centers, 2022 – 2030
- 8.16.1 Latin America Drug Addiction Treatment Market, by Treatment Centers, 2022 – 2030 (USD Billion)
- 8.17 Latin America Drug Addiction Treatment Market, by Drug Type, 2022 – 2030
- 8.17.1 Latin America Drug Addiction Treatment Market, by Drug Type, 2022 – 2030 (USD Billion)
- 8.18 Latin America Drug Addiction Treatment Market, by Distribution Channel, 2022 – 2030
- 8.18.1 Latin America Drug Addiction Treatment Market, by Distribution Channel, 2022 – 2030 (USD Billion)
- 8.19. The Middle-East and Africa
- 8.19.1 The Middle-East and Africa Drug Addiction Treatment Market, 2022 – 2030 (USD Billion)
- 8.19.1.1 The Middle-East and Africa Drug Addiction Treatment Market, by Country, 2022 – 2030 (USD Billion)
- 8.19.1 The Middle-East and Africa Drug Addiction Treatment Market, 2022 – 2030 (USD Billion)
- 8.20 The Middle-East and Africa Drug Addiction Treatment Market, by Treatment Centers, 2022 – 2030
- 8.20.1 The Middle-East and Africa Drug Addiction Treatment Market, by Treatment Centers, 2022 – 2030 (USD Billion)
- 8.21 The Middle-East and Africa Drug Addiction Treatment Market, by Drug Type, 2022 – 2030
- 8.21.1 The Middle-East and Africa Drug Addiction Treatment Market, by Drug Type, 2022 – 2030 (USD Billion)
- 8.22 The Middle-East and Africa Drug Addiction Treatment Market, by Distribution Channel, 2022 – 2030
- 8.22.1 The Middle-East and Africa Drug Addiction Treatment Market, by Distribution Channel, 2022 – 2030 (USD Billion)
- Chapter 9. Company Profiles
- 9.1 Alkermes Plc.
- 9.1.1 Overview
- 9.1.2 Financials
- 9.1.3 Product Portfolio
- 9.1.4 Business Strategy
- 9.1.5 Recent Developments
- 9.2 Glenmark Pharmaceuticals
- 9.2.1 Overview
- 9.2.2 Financials
- 9.2.3 Product Portfolio
- 9.2.4 Business Strategy
- 9.2.5 Recent Developments
- 9.3 Teva Pharmaceutical Industries Ltd.
- 9.3.1 Overview
- 9.3.2 Financials
- 9.3.3 Product Portfolio
- 9.3.4 Business Strategy
- 9.3.5 Recent Developments
- 9.4 Titan Pharmaceuticals Inc.
- 9.4.1 Overview
- 9.4.2 Financials
- 9.4.3 Product Portfolio
- 9.4.4 Business Strategy
- 9.4.5 Recent Developments
- 9.5 Pfizer Inc.
- 9.5.1 Overview
- 9.5.2 Financials
- 9.5.3 Product Portfolio
- 9.5.4 Business Strategy
- 9.5.5 Recent Developments
- 9.6 Johnson & Johnson
- 9.6.1 Overview
- 9.6.2 Financials
- 9.6.3 Product Portfolio
- 9.6.4 Business Strategy
- 9.6.5 Recent Developments
- 9.7 GlaxoSmithKline plc.
- 9.7.1 Overview
- 9.7.2 Financials
- 9.7.3 Product Portfolio
- 9.7.4 Business Strategy
- 9.7.5 Recent Developments
- 9.8 Perrigo Company plc.
- 9.8.1 Overview
- 9.8.2 Financials
- 9.8.3 Product Portfolio
- 9.8.4 Business Strategy
- 9.8.5 Recent Developments
- 9.9 Cipla Limited
- 9.9.1 Overview
- 9.9.2 Financials
- 9.9.3 Product Portfolio
- 9.9.4 Business Strategy
- 9.9.5 Recent Developments
- 9.10 Dr. Reddy’s Laboratories Limited
- 9.10.1 Overview
- 9.10.2 Financials
- 9.10.3 Product Portfolio
- 9.10.4 Business Strategy
- 9.10.5 Recent Developments
- 9.11 Hikma Pharmaceuticals Plc.
- 9.11.1 Overview
- 9.11.2 Financials
- 9.11.3 Product Portfolio
- 9.11.4 Business Strategy
- 9.11.5 Recent Developments
- 9.12 Indivior Inc.
- 9.12.1 Overview
- 9.12.2 Financials
- 9.12.3 Product Portfolio
- 9.12.4 Business Strategy
- 9.12.5 Recent Developments
- 9.13 Mylan N.V.
- 9.13.1 Overview
- 9.13.2 Financials
- 9.13.3 Product Portfolio
- 9.13.4 Business Strategy
- 9.13.5 Recent Developments
- 9.1 Alkermes Plc.
List Of Figures
Figures 1 to 29
List Of Tables
Tables 1 to 77
Report Methodology
In order to get the most precise estimates and forecasts possible, Custom Market Insights applies a detailed and adaptive research methodology centered on reducing deviations. For segregating and assessing quantitative aspects of the market, the company uses a combination of top-down and bottom-up approaches. Furthermore, data triangulation, which examines the market from three different aspects, is a recurring theme in all of our research reports. The following are critical components of the methodology used in all of our studies:
Preliminary Data Mining
On a broad scale, raw market information is retrieved and compiled. Data is constantly screened to make sure that only substantiated and verified sources are taken into account. Furthermore, data is mined from a plethora of reports in our archive and also a number of reputed & reliable paid databases. To gain a detailed understanding of the business, it is necessary to know the entire product life cycle and to facilitate this, we gather data from different suppliers, distributors, and buyers.
Surveys, technological conferences, and trade magazines are used to identify technical issues and trends. Technical data is also gathered from the standpoint of intellectual property, with a focus on freedom of movement and white space. The dynamics of the industry in terms of drivers, restraints, and valuation trends are also gathered. As a result, the content created contains a diverse range of original data, which is then cross-validated and verified with published sources.
Statistical Model
Simulation models are used to generate our business estimates and forecasts. For each study, a one-of-a-kind model is created. Data gathered for market dynamics, the digital landscape, development services, and valuation patterns are fed into the prototype and analyzed concurrently. These factors are compared, and their effect over the projected timeline is quantified using correlation, regression, and statistical modeling. Market forecasting is accomplished through the use of a combination of economic techniques, technical analysis, industry experience, and domain knowledge.
Short-term forecasting is typically done with econometric models, while long-term forecasting is done with technological market models. These are based on a synthesis of the technological environment, legal frameworks, economic outlook, and business regulations. Bottom-up market evaluation is favored, with crucial regional markets reviewed as distinct entities and data integration to acquire worldwide estimates. This is essential for gaining a thorough knowledge of the industry and ensuring that errors are kept to a minimum.
Some of the variables taken into account for forecasting are as follows:
• Industry drivers and constraints, as well as their current and projected impact
• The raw material case, as well as supply-versus-price trends
• Current volume and projected volume growth through 2030
We allocate weights to these variables and use weighted average analysis to determine the estimated market growth rate.
Primary Validation
This is the final step in our report’s estimating and forecasting process. Extensive primary interviews are carried out, both in-person and over the phone, to validate our findings and the assumptions that led to them.
Leading companies from across the supply chain, including suppliers, technology companies, subject matter experts, and buyers, use techniques like interviewing to ensure a comprehensive and non-biased overview of the business. These interviews are conducted all over the world, with the help of local staff and translators, to overcome language barriers.
Primary interviews not only aid with data validation, but also offer additional important insight into the industry, existing business scenario, and future projections, thereby improving the quality of our reports.
All of our estimates and forecasts are validated through extensive research work with key industry participants (KIPs), which typically include:
• Market leaders
• Suppliers of raw materials
• Suppliers of raw materials
• Buyers.
The following are the primary research objectives:
• To ensure the accuracy and acceptability of our data.
• Gaining an understanding of the current market and future projections.
Data Collection Matrix
| Perspective | Primary research | Secondary research |
| Supply-side |
|
|
| Demand-side |
|
|
Market Analysis Matrix
| Qualitative analysis | Quantitative analysis |
|
|
Prominent Players:
- Alkermes Plc.
- Glenmark Pharmaceuticals
- Teva Pharmaceutical Industries Ltd.
- Titan Pharmaceuticals Inc.
- Pfizer Inc.
- Johnson & Johnson
- GlaxoSmithKline plc.
- Perrigo Company plc.
- Cipla Limited
- Reddy’s Laboratories Limited
- Hikma Pharmaceuticals Plc.
- Indivior Inc.
- Mylan N.V.
- Others
FAQs
The global Drug Addiction Treatment market is expanding growth with a CAGR of approximately 15% during the forecast period (2022 to 2030).
PURCHASE OPTIONS
What You Get :
- PDF Report Format.
- Can be accessible by 1 single user.
- Free 25% or 40 hours of customisation.
- Free post-sale service assistance.
- 15% discount on your next purchase.
- Dedicated account Associate .
- Permission to print the report.
- Service guarantee available.
- PDF and Excel Datasheet Formats.
- Can be accessible upto 2 to 5 users.
- Free 35% or 60 hours of customisation.
- Free post-sale service assistance.
- 25% discount on your next purchase.
- Service guarantee available.
- Personalised market brief by author.
- Permission to print the report.
- Report in your Language.
- PDF, Excel and Power Point.
- Can be accessible by unlimited users.
- Free 40% or 80 hours of customisation.
- Free post-sale service assistance.
- 30% discount on your next purchase.
- Permission to print the report.
- Dedicated account manager.
- Service guarantee available.
- Report in your Language.
- Excel Datasheet Format.
- Customized access as per user request.
- Upgradable to other licenses.
- 15% discount on your next purchase.
- Free 20% or 10 hours of customisation.
- PDF, Excel, Power Point and Power BI.
- Every Year Free Update ( Apr – Apr)
- Personalized market brief by author
- Can be accessible by unlimited users.
- Free 50% or 90 hours of customization.
- Up to 50 Company Profiles
- Free post-sale service assistance with guarantee
- 40% discount on your next purchase.
- Permission to print the report.
- Dedicated account team.
- Service guarantee available.
- Report in your Language.